RecruitingOsteoarthritis of the Knee
Bone Marrow Aspirate Concentrate (BMAC) vs Corticosteroid Injection
Eligible age
18–70 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
Prospective single-masked (study participant will be masked), randomized controlled trial to examine the influence of BMAC on patient-reported outcomes (PROs) in patients with primary knee osteoarthritis.
Sponsor: Rush University Medical Center
You may qualify if…
- ✓ Patients between the ages of 18-70
- ✓ Long standing knee pain from osteoarthritis (KL grade 2-3) despite conventional treatments such as activity modification, weight loss, physical therapy, analgesics, nonsteroidal anti-inflammatory drugs, or injection therapy for at least 6 weeks
- ✓ 7-day average pain score of at least 4 on VAS scale
You may not qualify if…
- ✕ Systemic diseases (Diabetes, malignancies, infections, etc.)
- ✕ Post-traumatic arthritis
- ✕ Patient had intra-articular injection on affected knee in last three months
Where it's recruiting
Illinois
Chicago
Source: ClinicalTrials.gov · NCT05985785 · last updated 2025-08-13